Literature DB >> 17961521

Fibrillar beta-amyloid (Abeta) (1-42) elevates extracellular Abeta in cultured hippocampal neurons of adult rats.

Shohreh Majd1, Karim Rastegar, Asadollah Zarifkar, Mohammad Ali Takhshid.   

Abstract

Alzheimer's disease (AD) is a chronic disorder with progressive neurodegeneration associated with aging and is characterized by fibrillar beta-amyloid (Abeta) deposits in the brain. Although the increased production of Abeta seems to play a noticeable role in AD pathogenesis and its progression, all the mechanisms which are involved in this extracellular Abeta elevation are not known completely. In the present study, we used adult hippocampal neuronal culture as an in vitro model which is favorable for adult neurodegenerative diseases' studies. We introduced a toxic concentration for fibrillar Abeta1-42 in adult neurons which was much lower from the toxic concentration in embryonic neurons. To determine the effect of fibrillar Abeta1-42 which is the most toxic part of amyloid plaques, on extracellular Abeta1-40, as the main part of betaAPP proteolysis products, we treated the neurons with fibrillar Abeta1-42 at nontoxic concentrations of 2 x 10(-6), 2 x 10(-5) and 2 x 10(-4) microM and measured extracellular Abeta1-40. Our findings show that even very low levels of fibrillar Abeta1-42 can contribute to subsequent extracellular Abeta elevation in a dose dependent manner. These results suggest that even low levels of fibrillar Abeta may have deleterious actions if it remains in extracellular space for a period of time.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17961521     DOI: 10.1016/j.brainres.2007.09.033

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Reciprocal induction between α-synuclein and β-amyloid in adult rat neurons.

Authors:  Shohreh Majd; Fariba Chegini; Tim Chataway; Xin-Fu Zhou; Weiping Gai
Journal:  Neurotox Res       Date:  2012-05-19       Impact factor: 3.911

Review 2.  Novel avenues of drug discovery and biomarkers for diabetes mellitus.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  J Clin Pharmacol       Date:  2010-03-10       Impact factor: 3.126

3.  Development of an in vitro model to evaluate the regenerative capacity of adult brain-derived tyrosine hydroxylase-expressing dopaminergic neurons.

Authors:  Shohreh Majd; Arthur Smardencas; Clare L Parish; John Drago
Journal:  Neurochem Res       Date:  2011-03-06       Impact factor: 3.996

4.  Diabetes mellitus: channeling care through cellular discovery.

Authors:  Kenneth Maiese; Yan Chen Shang; Zhao Zhong Chong; Jinling Hou
Journal:  Curr Neurovasc Res       Date:  2010-02       Impact factor: 1.990

5.  Effects of proNGF on neuronal viability, neurite growth and amyloid-beta metabolism.

Authors:  Yan-Jiang Wang; Deborah Valadares; Ying Sun; Xin Wang; Jin-Hua Zhong; Xiao-Hong Liu; Shohreh Majd; Li Chen; Chang-Yue Gao; Si Chen; Yoon Lim; Anthony Pollard; Ernest A Salegio; Ernest Aguilar; Wei-Ping Gai; Miao Yang; Xin-Fu Zhou
Journal:  Neurotox Res       Date:  2009-08-13       Impact factor: 3.911

Review 6.  Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders.

Authors:  Zhao Zhong Chong; Yan Chen Shang; Lijie Zhang; Shaohui Wang; Kenneth Maiese
Journal:  Oxid Med Cell Longev       Date:  2010-11-01       Impact factor: 6.543

Review 7.  The vitamin nicotinamide: translating nutrition into clinical care.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Molecules       Date:  2009-09-09       Impact factor: 4.411

Review 8.  Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology.

Authors:  Kenneth Maiese; Jinling Hou; Zhao Zhong Chong; Yan Chen Shang
Journal:  ScientificWorldJournal       Date:  2009-10-02

Review 9.  Neuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathways.

Authors:  Shohreh Majd; John H Power; Hugh J M Grantham
Journal:  BMC Neurosci       Date:  2015-10-23       Impact factor: 3.288

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.